St.Louis University’s First Spinout, Antegrin Therapeutics, Gets Investment From BioGenerator
BioGenerator, the local nonprofit venture development group, announced Tuesday it will invest in Antegrin Therapeutics, a startup company that develops compounds to treat lung disease. Antegrin was founded based on science developed by researchers at St. Louis University and the Center for World Health & Medicine, the university’s center dedicated to the treatment of often […]